SPONSOR
Hubei Cancer Hospital
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Breast CancerImplant Breast ReconstructionNeoadjuvant RadiotherapyBreast-conserving Plastic SurgeryGranulomatous MastitisBreast NeoplasmsHormone Receptor-Positive Breast CancerAbemaciclibAbemaciclib-related DiarrheaDrug-induced Diarrhea
Hubei Cancer Hospital is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Breast Cancer, Implant Breast Reconstruction, Neoadjuvant Radiotherapy, Breast-conserving Plastic Surgery.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hubei Cancer Hospital
How many clinical trials has Hubei Cancer Hospital sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Hubei Cancer Hospital, of which 5 are actively recruiting participants. These trials cover conditions including Breast Cancer, Implant Breast Reconstruction, Neoadjuvant Radiotherapy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hubei Cancer Hospital research focus on?
Hubei Cancer Hospital clinical trials span Breast Cancer, Implant Breast Reconstruction, Neoadjuvant Radiotherapy, Breast-conserving Plastic Surgery, Granulomatous Mastitis, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hubei Cancer Hospital clinical trial?
To participate in a Hubei Cancer Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hubei Cancer Hospital trials with current recruitment status updated daily.
Clinical Trials by Hubei Cancer Hospital
NCT05992870
Recruiting
Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction
Breast Cancer
NCT06712524
Recruiting
Effect of Different Surgical Approaches of Granulomatous Mastitis
Breast-conserving Plastic Surgery
NCT07264998
Recruiting
Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea
Breast Neoplasms
NCT06401005 Phase 2
Recruiting
SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)
Breast Cancer
NCT06037733
Recruiting
Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy
Advanced Non-Small Cell Squamous Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology